In addition, insulin and hyperglycemia stimulate IGF1 production, and the binding of IGF1 to its receptor activates the downstream signaling pathways that involve PI3K/AKT/mTOR and the RAS/RAF/mitogen-activated protein kinase (MAPK) pathways [30,31,32]. The gene discussed is IGF1; the disease is Hyperglycemia.